Provided by Tiger Trade Technology Pte. Ltd.

INNOVENT BIO

99.700
-2.700-2.64%
Volume:6.90M
Turnover:692.52M
Market Cap:173.88B
PE:181.97
High:103.300
Open:103.200
Low:98.550
Close:102.400
52wk High:109.100
52wk Low:69.550
Shares:1.74B
HK Float Shares:1.74B
Volume Ratio:0.74
T/O Rate:0.40%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.548
ROE:5.01%
ROA:1.56%
PB:7.71
PE(LYR):181.97
PS:11.44

Loading ...

Decline Persists, Innovent Bio Plunges Over 7%! Hong Kong Stock Connect Innovative Drug Sector Logs Fourth Consecutive Drop, Fund ETF 520880 Attracts Another 100 Million Yuan Inflows. Institutions Highlight Catalyst from Upcoming Industry Conference

Deep News
·
May 15

Stock Track | Innovent Biologics Plummets 8.07% in Early Trading Following Founder's Share Sale

Stock Track
·
May 15

INNOVENT BIO Shares Slide on Founder's Share Sale

Stock News
·
May 15

Hong Kong Stocks Decrease 0.7% In Early Trading

Dow Jones
·
May 15

Innovent presents Phase 3 mazdutide obesity, diabetes trial results at ADA 2026

Reuters
·
May 13

JPMorgan: National Reimbursement Drug List Updates Accelerate Commercialization of Innovative Drugs, Top Picks Include Innovent Bio (01801)

Stock News
·
May 12

Citigroup: Fundamentals of China's Healthcare Sector Show Sustained Improvement, Top Picks Include WuXi AppTec (02359)

Stock News
·
May 11

Innovent says NMPA grants IBI363 breakthrough therapy status for MSS colorectal cancer

Reuters
·
May 11

Innovent Announces Ibi363 (Pd-1/Il-2Α-Bias Bispecific Fusion Protein) Received Third Nmpa Breakthrough Therapy Designation for Mss/Pmmr Metastatic Colorectal Cancer

THOMSON REUTERS
·
May 11

AI Frenzy Shifts from Hardware to Applications, Musk-Related Concepts Gain Traction

Stock News
·
May 07

Innovent Biologics Issues 3.05 Million New Shares in April, Expanding Share Base to 1.74 Billion

Bulletin Express
·
May 07

The Strong Earnings Posted By Innovent Biologics (HKG:1801) Are A Good Indication Of The Strength Of The Business

Simply Wall St.
·
May 06

Goldman Sachs Increases Price Target for Innovent Bio to HK$105.94, Maintains Buy Rating

Stock News
·
May 04

CICC Maintains "Outperform" Rating on Innovent Biologics with HK$118.3 Target Price

Stock News
·
May 04

May 2026 Hong Kong Stock Market Investment Strategy and Top Ten Stock Picks

Stock News
·
May 03

Innovent Biologics' Product Revenue Jumps 50% in Q1 2026

MT Newswires Live
·
Apr 30

Stock Track | Innovent Bio Soars 5.06% Intraday on Strong Q1 Revenue Growth Exceeding 50%

Stock Track
·
Apr 30

BUZZ-Innovent Biologics set for biggest rise in 2 weeks on robust Q1 revenue growth

Reuters
·
Apr 30

INNOVENT BIO Shares Surge Over 5% on Strong Q1 Product Revenue Growth and Pipeline Progress

Stock News
·
Apr 30

BRIEF-Innovent Biologics Posts Q1 2026 Total Product Revenue Over RMB3.8 Billion

Reuters
·
Apr 30